About Mecuris
Mecuris is a company based in Munchen (Germany) founded in 2015 by Simon Weidert and Felix Gundlack. It operates as a B2B. Mecuris has raised $8.13 million across 3 funding rounds from investors including Vesalius Biocapital Partners, Sana Kliniken and Bayern Kapital. The company has 34 employees as of December 31, 2020. Mecuris operates in a competitive market with competitors including Restor3D, Unyq, Motorica, Open Bionics and Focus Motion, among others.
- Headquarter Munchen, Germany
- Employees 34 as on 31 Dec, 2020
- Founders Simon Weidert, Felix Gundlack
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mecuris Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.13 M (USD)
in 3 rounds
-
Latest Funding Round
$4 M (USD), Series A
Jan 13, 2020
-
Investors
Vesalius Biocapital Partners
& 5 more
-
Employee Count
34
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Mecuris
Unlock access to complete
Unlock access to complete
Funding Insights of Mecuris
Mecuris has successfully raised a total of $8.13M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mecuris
Mecuris has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Vesalius Biocapital Partners, Sana Kliniken and Bayern Kapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
Life sciences-focused VC firm investing in Europe and Canada
|
Locked | Locked | Locked |
Investor details for Mecuris
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mecuris
Investment portfolio details for Mecuris
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mecuris
Detailed financials for Mecuris
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mecuris Comparisons
Peer comparison for Mecuris
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mecuris
Mecuris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Restor3D, Unyq, Motorica, Open Bionics and Focus Motion, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
3D printing technology is developed for human body reconstruction.
|
|
| Locked | Locked | Locked |
Custom 3D-printed prosthetic fairings and accessories are supplied to amputees.
|
|
| Locked | Locked | Locked |
3D-printed upper limb prosthetics are developed for injury restoration.
|
|
| Locked | Locked | Locked |
Robotic prosthetic hands are manufactured using 3D printing technology.
|
|
| Locked | Locked | Locked |
Provider of AI-based wearables and application for health, wellness and fitness
|
Detailed competitors of Mecuris
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mecuris
Complete news archive for Mecuris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mecuris
Mecuris was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Mecuris is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Mecuris is a funded company, having raised a total of $8.13M across 3 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Mecuris is 34.
Mecuris operates with a B2B model, focusing on providing healthcare solutions, medical technology, orthopedics, and design software. Offers digital CADCAM solutions for designing orthopedic implants. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.
Mecuris has 6 investors. Key investors include Vesalius Biocapital Partners, Sana Kliniken, Bayern Kapital, High-Tech Gründerfonds, and MULCAN.